Open AccessPhase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
Author(s) -
Antonius A. Miller,
Daryl J. Murry,
Kouros Owzar,
Donna Hollis,
Erin B. Kennedy,
Ghassan K. AbouAlfa,
Apurva A. Desai,
Jimmy J. Hwang,
Miguel A. VillalonaCalero,
E. Claire Dees,
Lionel D. Lewis,
Marwan Fakih,
Martin J. Edelman,
Fred Millard,
Richard C. Frank,
Raymond J. Hohl,
Mark J. Ratain
Publication year - 2009
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/wcm6-pa53
Subject(s) - sorafenib , pharmacokinetics , medicine , hepatic dysfunction , phase (matter) , oncology , urology , hepatocellular carcinoma , chemistry , organic chemistry